Rhinomed

TRY our products Today.

Select a product below to learn more and purchase online.

Range of Sizes Available
View TURBINE

Range of Sizes Available
View MUTE

Range of Sizes Available
View PRONTO

RNO SIGNS 12 YEAR LICENSING AGREEMENT WITH USA’S LARGEST MEDICAL CANNABIS OPERATOR

Rhinomed (ASX:RNO) is pleased to advise investors it has signed a 12-year exclusive licensing agreement of its nasal platform technology with Columbia Care LLC.
Read More
APPENDIX 4E PRELIMINARY FINAL REPORT

Rhinomed (ASX:RNO) a leader in nasal respiratory technology, today released the Appendix 4E Preliminary Final Report
Read More
BUSINESS UPDATE – JUNE QUARTER CASH FLOW REPORT

Rhinomed (ASX:RNO) a leader in nasal respiratory technology, today announced a pivotal year of growth and milestone achievement. The company can report record recognised revenues for FY18 Q4 of $874k - a 71% increase over FY18 Q3 and totalling $2.13m for the full FY18, up 24% on FY17.
Read More